Antibodies against the Epstein-Barr virus indicate risk of multiple sclerosis Biomarker discovered: A new blood test can detect the risk of developing multiple sclerosis (MS) years before the first symptoms appear. The test measures the level of antibodies that bind both the body's own structures and the Epstein-Barr virus, which serve as indicators of MS. This could lead to earlier diagnosis and treatment in the future, delaying or preventing the onset of the neurodegenerati

Gene Activity on the X and Y Chromosomes Influences Height XY becomes taller than XX: Researchers have discovered that a specific gene on the X and Y chromosomes plays an important role in our height. According to the study, this gene is more active on the male Y chromosome than on the second X chromosome in women. This gives men additional height. However, height is also influenced by other factors, including hormones and chromosome number. The method could also be used in t

Archaea Could Play a Previously Underestimated Role in the Microbiome A new roommate: Scientists have discovered a previously unknown microbe in our gut. It's not a bacterium, but a species of archaea. The species, dubbed Methanobrevibacter intestini, produces the gas methane – similar to a newly discovered variant of the archaea species Methanobrevibacter smithii. These findings suggest that our intestinal flora is significantly more influenced by archaea than previously tho

Antibody drug against Alzheimer's now also available in Europe How Lecanemab works against dementia and who is eligible for it Hope for Alzheimer's patients: Earlier this week, the European Commission approved the first antibody drug for the treatment of Alzheimer's in Europe. The active ingredient, lecanemab, can slow the progression of the disease in some early-stage Alzheimer's patients, but cannot cure or stop it. Early diagnosis of the first symptoms of dementia remains